Navigation Links
Some skin cancer may be mediated by primary cilia activity
Date:8/23/2009

Tiny, solitary spikes that stick out of nearly every cell in the body play a central role in a type of skin cancer, new research has found. The discovery in mice shows that the microscopic structures known as primary cilia can either suppress or promote this skin cancer, depending on the mutation triggering the disease.

The finding suggests that drugs that boost or block primary cilia activity could offer a new strategy against cancer.

Unlike the more familiar motile cilia, primary cilia do not move, and only one pokes out of each cell. They have recently been discovered to play an essential role in assuring normal embryological development.

The new study focused on basal cell carcinoma, the most common cancer in the United States. It is published in the August 23, 2009 advanced online issue of "Nature Medicine." A companion article in the same issue reports a similar discovery regarding a type of brain tumor in children known as medulloblastoma. (See related UCSF news release on this finding.)

The two studies were led by scientists at the University of California, San Francisco, and they are the first demonstrations that primary cilia are required for some kinds of cancer. They are also the first reports that these cilia can protrude from cancer cells, as they do from most normal cells.

If the basal cell carcinoma finding is confirmed in people, the discovery raises the possibility of new cancer treatment strategies, said Jeremy Reiter, MD, PhD, senior author of that paper. Reiter is assistant professor of biochemistry and biophysics, an investigator at the Cardiovascular Research Institute, the Diabetes Center and the Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research at UCSF. In July, President Obama named him as a recipient of the Presidential Early Career Award for Scientists and Engineers for his research on the links between cilia and cancer.

Although they are relegated to the outsk
'/>"/>

Contact: Jennifer O'Brien
jobrien@pubaff.ucsf.edu
415-476-2557
University of California - San Francisco
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Green tea boosts production of detox enzymes, rendering cancerous chemicals harmless
2. A study by the MUHC and McGill University opens a new door to understanding cancer
3. ESF EURYI award winner aims to stop cancer cells reading their own DNA
4. Protein chatter linked to cancer activation
5. Newly created cancer stem cells could aid breast cancer research
6. Western diet linked to increased risk of colon cancer recurrence
7. Obesity and lack of exercise could enhance the risk of pancreatic cancer
8. Low levels of key protein may indicate pancreatic cancer risk
9. Birth records hold pancreatic cancer clue
10. Many parents at-risk for cancer disclose genetic test results to children
11. A new radiation therapy treatment developed for head and neck cancer patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... Nov. 19, 2014  Earlier this year Donald ... College, and one of the most prolific inventors in ... are transmitted from Smartphones to third party agencies. Spector ... has one of the earliest known patents in this ... in the military, child care, elder care and hospital ...
(Date:11/21/2014)... Nov. 20, 2014   Atmel® Corporation (NASDAQ: ... (MCU) and touch technology solutions, today launched the industry,s ... with the widest V cc range from 1.7V ... and faster I 2 C bus communication speeds, and ... memory making them ideal for consumer, industrial, computer, and ...
(Date:11/18/2014)... The Parenteral Drug Association (PDA) today confirmed that seven officials ... least seven more will participate in the upcoming 2014 PDA ... Washington D.C. , Dec. 2-4. ... the regulatory agencies in the United States ... to help advance the use of metrics in the regulatory ...
Breaking Biology News(10 mins):Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 2Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 3Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 4Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 2Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 3Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 4FDA's Janet Woodcock, EMA's Emer Cooke Headline PDA Quality Metrics Conference 2
... bacteria exist as aggressive pathogens, causing diseases ranging from ... syndrome, others play a less malevolent role and some ... study, Cheryl Nickerson and her group at ASU,s Biodesign ... Van de Wiele and lead author Rosemarie De Weirdt ...
... participation in scientific research has deep roots in the ... has taken off spectacularly from launch pads across the ... communications technology and a sea change in a scientific ... Citizen science, crowd-sourced science, DIY research, volunteer monitoring, ...
... A study comparing whether endothelial colony-forming cells (ECFCs) derived from ... are more proliferative and better for forming new blood vessels ... vasculogenic., The study, carried out by researchers at the Indiana ... Cell Medicine [2(3)] and is freely available on-line ...
Cached Biology News:Beneficial bacteria may help ward off infection 2Beneficial bacteria may help ward off infection 3Beneficial bacteria may help ward off infection 4Beneficial bacteria may help ward off infection 5Inaugural cross-disciplinary Public Participation in Scientific Research conference 2Blood vessel forming potential of stem cells from human placenta and umbilical cord blood 2
(Date:11/26/2014)... November 25, 2014 Continuing its award-winning ... earned three prestigious MarCom Awards for outstanding creative achievement ... a Platinum MarCom Award, the organization’s top honor, in ... St. Louis held in April of this year. The ... 14,000 attendees. Additionally, Nerium was awarded a Gold MarCom ...
(Date:11/26/2014)... DE (PRWEB) November 26, 2014 ... Heroes recognition reception on December 5, 2014, in San ... meeting. The MPN Heroes event will honor clinicians, caregivers, ... field of myeloproliferative neoplasms (MPNs). , Special guest ... discuss his family's cancer journey at the reception. ...
(Date:11/26/2014)...  Roka Bioscience, Inc. (NASDAQ: ROKA ), a ... the detection of foodborne pathogens, today announced that Paul ... th Annual Healthcare Conference on December 2, 2014 at ... York Palace in New York, NY . ... Company, its operations, strategies and prospects may be discussed. To ...
(Date:11/24/2014)... 2014   First ... Elsevier , a world-leading provider of scientific, ... announce the launch of the latest title in the ... in Food Science . ... a new platform to keep up-to-date with the expanding volume ...
Breaking Biology Technology:Nerium International™ Wins One Platinum, Two Gold MarCom Awards 2CURE Magazine and Incyte to Honor MPN Heroes 2CURE Magazine and Incyte to Honor MPN Heroes 3CURE Magazine and Incyte to Honor MPN Heroes 4Roka Bioscience to Present at the Piper Jaffray Healthcare Conference 2Elsevier Announces Launch of New Journal: Current Opinion in Food Science 2Elsevier Announces Launch of New Journal: Current Opinion in Food Science 3
... and OSLO, March 4 Pharmexa A/S and Affitech ... agreement to merge,the two companies by means of a ... Norwegian company, Affitech AS. The purpose of the merger ... vaccine business,into a company focused on the research and ...
... milestones, - Strong R&D investments, especially in EHT Dx21 and EHT ... Recruitment of 311 samples achieved for EHT Dx21, - ... Expansion of the strategic collaboration with Allergan and extension, ... of a new Management Board, - New positioning of Genomic Services ...
... highlights the importance and challenges of ... America. To move beyond the current crisis, we ... knowledge-intensive jobs, invest in "green" science and engineering ... based industries and workers. , Nanotechnologywhich some scientists ...
Cached Biology Technology:Pharmexa and Affitech to Combine Operations to Create a New Antibody Therapeutics Company 2Pharmexa and Affitech to Combine Operations to Create a New Antibody Therapeutics Company 3ExonHit Therapeutics Invested Strongly in 2008 for Pivotal 2009 Results 2ExonHit Therapeutics Invested Strongly in 2008 for Pivotal 2009 Results 3ExonHit Therapeutics Invested Strongly in 2008 for Pivotal 2009 Results 4ExonHit Therapeutics Invested Strongly in 2008 for Pivotal 2009 Results 5ExonHit Therapeutics Invested Strongly in 2008 for Pivotal 2009 Results 6ExonHit Therapeutics Invested Strongly in 2008 for Pivotal 2009 Results 7ExonHit Therapeutics Invested Strongly in 2008 for Pivotal 2009 Results 8ExonHit Therapeutics Invested Strongly in 2008 for Pivotal 2009 Results 9ExonHit Therapeutics Invested Strongly in 2008 for Pivotal 2009 Results 10ExonHit Therapeutics Invested Strongly in 2008 for Pivotal 2009 Results 11Nanotechnology: Will it drive a new innovation economy for the US? 2Nanotechnology: Will it drive a new innovation economy for the US? 3
IHC detection kit for PCNA in cells and tissues...
... Immunogen: Synthetic peptide derived from the ... protein. Specificity: Reacts with the ... Reactivity: Human Mouse (positive controls: WNT1-transfected ... lysates and mouse Mouse-1 cell lysates). ...
The pYES2 vector is designed for native expression of your protein of interest in S. cerevisiae. It contains the URA3 gene for selection in yeast and 2 origin for high-copy maintenance....
... cAMP - [125I] Direct SPA ... SPA.Includes lysis reagents that eliminate lengthy ... cAMP measurement (optional use).Range: 1.32-84.28 ng/ml ... pmol/ml).Overnight protocol.Store at 2-8 C. Category: ...
Biology Products: